{"id":1068418,"date":"2024-01-20T02:36:17","date_gmt":"2024-01-20T07:36:17","guid":{"rendered":"https:\/\/www.immortalitymedicine.tv\/processa-pharmaceuticals-announces-expansion-of-ngc-cap-program-into-advanced-or-metastatic-breast-cancer\/"},"modified":"2024-08-18T11:47:02","modified_gmt":"2024-08-18T15:47:02","slug":"processa-pharmaceuticals-announces-expansion-of-ngc-cap-program-into-advanced-or-metastatic-breast-cancer","status":"publish","type":"post","link":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/global-news-feed\/processa-pharmaceuticals-announces-expansion-of-ngc-cap-program-into-advanced-or-metastatic-breast-cancer.php","title":{"rendered":"Processa Pharmaceuticals Announces Expansion of NGC-Cap Program into Advanced or Metastatic Breast Cancer"},"content":{"rendered":"<p><![CDATA[FDA and Processa agree to expand NGC-Cap development into breast cancer providing a more efficient path to approval]]><\/p>\n<p>View original post here:<br \/>\n<a target=\"_blank\" rel=\"nofollow noopener\" href=\"https:\/\/www.globenewswire.com\/news-release\/2024\/01\/19\/2812259\/0\/en\/Processa-Pharmaceuticals-Announces-Expansion-of-NGC-Cap-Program-into-Advanced-or-Metastatic-Breast-Cancer.html?f=22&amp;fvtc=5&amp;fvtv=46634288\" title=\"Processa Pharmaceuticals Announces Expansion of NGC-Cap Program into Advanced or Metastatic Breast Cancer\">Processa Pharmaceuticals Announces Expansion of NGC-Cap Program into Advanced or Metastatic Breast Cancer<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>View original post here: Processa Pharmaceuticals Announces Expansion of NGC-Cap Program into Advanced or Metastatic Breast Cancer <a href=\"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/global-news-feed\/processa-pharmaceuticals-announces-expansion-of-ngc-cap-program-into-advanced-or-metastatic-breast-cancer.php\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"limit_modified_date":"","last_modified_date":"","_lmt_disableupdate":"","_lmt_disable":"","footnotes":""},"categories":[1246886],"tags":[],"class_list":["post-1068418","post","type-post","status-publish","format-standard","hentry","category-global-news-feed"],"modified_by":null,"_links":{"self":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/1068418"}],"collection":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/comments?post=1068418"}],"version-history":[{"count":0,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/1068418\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/media?parent=1068418"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/categories?post=1068418"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/tags?post=1068418"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}